Abstract
High-altitude pulmonary edema (HAPE) is a lethal, noncardiogenic form of pulmonary edema that afflicts susceptible individuals after rapid ascent to high altitude above 2,500 m. Prevention of HAPE is achieved most effectively by gradual ascent allowing time for proper acclimatization. Certain prophylactic medications may further reduce the risk of ascending to high altitude in individuals with a prior history of HAPE. The most effective and reliable treatment of HAPE is immediate descent and administration of supplemental oxygen.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 115-119 |
| Number of pages | 5 |
| Journal | Current Sports Medicine Reports |
| Volume | 12 |
| Issue number | 2 |
| DOIs | |
| State | Published - Mar 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Orthopedics and Sports Medicine
- Public Health, Environmental and Occupational Health
Fingerprint
Dive into the research topics of 'High-altitude pulmonary edema: Diagnosis, prevention, and treatment'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS